NUCLEA BIOTECHNOLOGIES, INC.

Profile

Company Names

NUCLEA BIOTECHNOLOGIES, INC.
NUCLEA BIOTECHNOLOGIES, LLC

Addresses

46 ELM STREET, PITTSFIELD, MA 01201

105 SOUTH STREET, PITTSFIELD, MA 01201

Phone Numbers

(413) 749-4705
(413) 445-9930

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$20,881,970.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2013-02-06 
$1,066,970.00 
INDEFINITE 
INDEFINITE 
Equity 
7
2012-07-30 
$5,000,000.00 
INDEFINITE 
INDEFINITE 
Equity 
6
2012-04-27 
$554,850.00 
INDEFINITE 
INDEFINITE 
Equity 
5
2012-03-30 
$1,931,700.00 
INDEFINITE 
INDEFINITE 
Equity 
4
2011-08-10 
$3,000,000.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2010-11-30 
$425,000.00 
$4,000,000.00 
$3,575,000.00 
Debt 
2
2010-11-24 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2009-06-10 
$8,903,450.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAULA 
 
EVANS 
EXECUTIVE OFFICER
NUCLEA BIOTECHNOLOGIES, INC.   |  GENETX BIOTHERAPEUTICS LLC
PAULA 
C. 
EVANS 
EXECUTIVE OFFICER
NUCLEA BIOTECHNOLOGIES, LLC
WILLIAM 
R. 
HARMAN 
DIRECTOR
NUCLEA BIOTECHNOLOGIES, LLC   |  NUCLEA BIOTECHNOLOGIES, INC.
JAMES 
W. 
LEWIS 
DIRECTOR
NUCLEA BIOTECHNOLOGIES, LLC   |  KNIGHT CAPITAL GROUP, INC.   |  NUCLEA BIOTECHNOLOGIES, INC.
PATRICK 
J. 
MURACA 
EXECUTIVE OFFICER, DIRECTOR
NUCLEA BIOTECHNOLOGIES, LLC   |  NUCLEA BIOTECHNOLOGIES, INC.
ROBERT 
 
PIERCE 
EXECUTIVE OFFICER
NUCLEA BIOTECHNOLOGIES, INC.   |  PRICESIMPLICITY, INC.   |  DECISIONNEXT, INC.
CHARLES 
P. 
STETSON 
DIRECTOR
NUCLEA BIOTECHNOLOGIES, INC.
DENNIS 
K. 
STONE 
DIRECTOR
NUCLEA BIOTECHNOLOGIES, INC.   |  BELLICUM PHARMACEUTICALS, INC   |  SOLITON, INC.
RICHARD 
 
VIETOR 
DIRECTOR
NUCLEA BIOTECHNOLOGIES, INC.   |  NANOLUMENS, INC   |  INFACARE PHARMACEUTICAL CORP
RICHARD 
R. 
VIETOR 
DIRECTOR
NUCLEA BIOTECHNOLOGIES, LLC   |  BACTERIOSCAN, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-02-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-06 
2012-08-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-30 
2012-05-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-27 
2012-04-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-30 
2011-08-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-10 
2010-12-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-11-30 
2010-12-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-24 
2010-11-01
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-10 
2009-10-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-10 
2009-06-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#